Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:approvedBy |
2005
adolescents adults |
| gptkbp:boosterInterval |
every 10 years
|
| gptkbp:broadcastOn |
single dose booster
|
| gptkbp:contains |
tetanus toxoid
acellular pertussis components reduced diphtheria toxoid |
| gptkbp:contraindication |
severe allergic reaction to previous dose
|
| gptkbp:fullName |
gptkb:Tetanus,_Diphtheria,_and_Pertussis_vaccine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tdap
|
| gptkbp:marketedAs |
gptkb:Sanofi
GlaxoSmithKline |
| gptkbp:protectedBy |
diphtheria
tetanus pertussis |
| gptkbp:recommendation |
gptkb:Centers_for_Disease_Control_and_Prevention
pregnant women healthcare workers |
| gptkbp:sideEffect |
fever
fatigue headache pain at injection site |
| gptkbp:usedFor |
booster immunization
|
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:bfsParent |
gptkb:Pertussis
|
| gptkbp:bfsLayer |
5
|